Recent research has revealed that a critical mutation may have facilitated the rapid global spread of the JN.1 variant of COVID-19, despite widespread vaccination and earlier infections among many individuals.
The key mutation in JN.1 has allowed it to evade antibody responses, significantly contributing to its global dissemination. JN.1, a subvariant of omicron, was first detected in Luxembourg in August 2023 and by the end of January, it represented a staggering 88%, 85%, and 77% of infections in the US, UK, and Australia, respectively. In contrast, its predecessor, BA.2.86, never exceeded 5% of known global infections.
As JN.1 and its variants continue to dominate COVID-19 cases worldwide, researchers sought to understand the mechanisms behind its rapid spread. Genetic analysis has indicated a notable mutation in its spike protein, crucial for the virus’s ability to infect host cells.
The study involved analysis of 899 types of antibodies from blood samples collected from individuals who had received multiple doses of an mRNA vaccine and had prior infections. Experiments revealed that out of 899 antibodies, only 23 were effective against JN.1, highlighting its ability to evade immune defenses.
Investigation into the spike protein mutation showed a substitution that weakened the interaction of antibodies with the virus, helping JN.1 evade neutralizing antibodies that typically prevent infection.
Interestingly, the antibodies that did neutralize JN.1 originated from individuals exhibiting what researchers term “super hybrid” immunity—having received three mRNA vaccine doses and experienced prior infections with both the original SARS-CoV-2 strain and an omicron variant.
While JN.1’s mutation enhances its ability to evade antibody response, it does not appear to cause more severe illness than earlier variants. This resilience is likely due to the robust function of other immune system components, such as T-cells, which continue to provide protection against severe illness.
The antibodies studied are comparable to those found in global populations; however, the research underscores the need for larger studies to validate these findings.
Topics:
